Table 2.
Incidence rate of all cancers in patients with and without gout (controls)
| Variable | Control group | Patients with gout | IRR | ||
|---|---|---|---|---|---|
|
|
|
||||
| IR | 95% CI | IR | 95% CI | ||
| Overall cancers | 1,001.7 | 986.5–1,017.2 | 1,082.8 | 1,067.0–1,098.9 | 1.08 |
|
| |||||
| Head and neck cancer | 15.0 | 13.3–17.0 | 15.9 | 14.1–17.9 | 1.06 |
|
| |||||
| Esophageal cancer | 7.4 | 6.2–8.9 | 10.5 | 9.0–12.2 | 1.41 |
|
| |||||
| Stomach cancer | 106.9 | 102.0–112.0 | 119.6 | 114.4–125.0 | 1.12 |
|
| |||||
| Colon cancer | 106.3 | 101.4–111.4 | 121.0 | 115.8–126.5 | 1.14 |
|
| |||||
| Liver cancer | 108.0 | 103.1–113.2 | 122.7 | 117.4–128.2 | 1.14 |
|
| |||||
| Pancreatic cancer | 43.7 | 40.6–47.0 | 51.1 | 47.8–54.7 | 1.17 |
|
| |||||
| Lung cancer | 89.8 | 85.3–94.5 | 98.6 | 93.9–103.5 | 1.10 |
|
| |||||
| Skin cancer | 4.2 | 3.3–5.3 | 3.5 | 2.7–4.5 | 0.84 |
|
| |||||
| Breast cancer | 21.2 | 19.1–23.6 | 22.2 | 20.0–24.6 | 1.05 |
|
| |||||
| Cervical cancer | 5.4 | 4.4–6.6 | 4.5 | 3.6–5.6 | 0.83 |
|
| |||||
| Endometrial cancer | 2.9 | 2.2–3.8 | 4.0 | 3.2–5.1 | 1.40 |
|
| |||||
| Ovarian cancer | 6.2 | 5.1–7.5 | 9.5 | 8.1–11.1 | 1.53 |
|
| |||||
| Renal cancer | 21.6 | 19.4–24.0 | 30.5 | 27.9–33.3 | 1.41 |
|
| |||||
| Prostate cancer | 198.5 | 191.7–205.4 | 180.7 | 174.3–187.4 | 0.91 |
|
| |||||
| Bladder cancer | 29.1 | 26.6–31.8 | 34.3 | 31.6–37.3 | 1.18 |
|
| |||||
| Thyroid cancer | 67.1 | 63.2–71.2 | 72.7 | 68.7–76.9 | 1.08 |
|
| |||||
| Lymphoma | 12.3 | 10.7–14.1 | 13.1 | 11.5–15.0 | 1.07 |
|
| |||||
| Leukemia | 11.0 | 9.5–12.8 | 10.9 | 9.4–12.6 | 0.99 |
IR, incidence rate; CI, confidence interval; IRR, incidence rate ratio.